Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkx153DOI Listing

Publication Analysis

Top Keywords

trimethoprim/sulfamethoxazole versus
4
versus vancomycin
4
vancomycin treatment
4
treatment healthcare/ventilator-associated
4
healthcare/ventilator-associated mrsa
4
mrsa pneumonia
4
pneumonia case-control
4
case-control study
4
trimethoprim/sulfamethoxazole
1
vancomycin
1

Similar Publications

Objectives: This study aimed to assess the frequency of co-resistance to antibiotics recommended in acute pyelonephritis among Escherichia coli clinical strains isolated from urinary tract infections (UTIs) acquired in community or nursing homes (NHs), and to identify situations without alternatives to fluoroquinolones (FQs).

Methods: All antimicrobial susceptibility test (AST) results of E. coli culture-positive urine samples from females living in the community or in NHs, collected through a large network of clinical laboratories in 2020 in France, were included.

View Article and Find Full Text PDF

Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study.

Ann Emerg Med

November 2024

Department of Emergency Medicine and Pharmacy, University of Iowa, Iowa City, IA. Electronic address:

Study Objective: The primary objective of our study was to compare the effectiveness of oral cephalosporins versus fluroquinolones and trimethoprim/sulfamethoxazole (TMP-SMX) for the treatment of pyelonephritis in patients discharged home from the emergency department (ED).

Methods: This was a multicenter, retrospective, observational cohort study of 11 geographically diverse US EDs. Patients aged ≥18 years diagnosed with pyelonephritis and discharged home from the ED between January 1, 2021 and October 31, 2023 were included.

View Article and Find Full Text PDF

Studies of fluoroquinolone (FQ) safety across indications show increased collagen/neurological adverse event (AE) risk, yet patients still receive FQs for uncomplicated urinary tract infections (uUTIs). This retrospective, cohort study investigated the risk of collagen/neurological AEs of special interest (AESIs) with short-term FQ use versus standard-of-care antibiotics (trimethoprim-sulfamethoxazole [SXT], nitrofurantoin [NTF]) among female outpatients with uUTIs. This study was conducted between December 2009 and 2019 using Optum's de-identified Clinformatics Data Mart Database.

View Article and Find Full Text PDF

Background: Patients with an active cancer are more likely to develop melioidosis, but the characteristics and clinical course of melioidosis in patients with cancer have not been examined in detail. Trimethoprim/sulfamethoxazole (TMP-SMX) prophylaxis is prescribed to prevent melioidosis in patients receiving immune suppressing anti-cancer therapy in some jurisdictions-and is recommended in national Australian guidelines-however the risks and benefits of this strategy are incompletely defined.

Methods: The study took place in Far North Queensland (FNQ) in tropical Australia.

View Article and Find Full Text PDF

Background: Antibiotic prescription practices differ between countries, influencing regional antimicrobial resistance prevalence. However, comparisons of clonal diversity among resistant bacteria in countries with different prescribing practices are rare. The rise of fluoroquinolone-resistant (FQREC), often multidrug-resistant, exacerbates global antibiotic resistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!